IGC Pharma
IGC
#10740
Rank
C$29.31 M
Marketcap
C$0.25
Share price
-4.61%
Change (1 day)
-47.31%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): C-$0.13

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is C-$0.13. In 2025 the company made an earnings per share (EPS) of C-$0.13 an increase over its 2024 EPS that were of C-$0.31.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.13-2.32%
2025C-$0.13-59.09%
2024C-$0.31-0%
2023C-$0.31-26.67%
2022C-$0.4342.86%
2021C-$0.3010.53%
2020C-$0.2746.15%
2019C-$0.19116.67%
2018C-$0.08564-14.29%
2017C-$0.09992-58.82%
2016C-$0.24-45.16%
2015C-$0.44-16.22%
2014C-$0.5315.62%
2013C-$0.46-87.97%
2012C-$3.80-80.15%
2011C-$19.13219.05%
2010C-$6.00740%
2009C-$0.71-91.8%
2008C-$8.71-654.55%
2007C$1.57-178.57%
2006C-$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
C$25.81-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
C$5.84-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
C-$8.65 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA